FINWIRES · TerminalLIVE
FINWIRES

Morgan Stanley Downgrades Aardvark Therapeutics to Underweight From Equalweight, Cuts Price Target to $3 From $7

By

Aardvark Therapeutics (AARD) has an average rating of overweight and mean price target of $18.45, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Research

Morgan Stanley Downgrades Viking Holdings to Equalweight From Overweight, Raises Price Target to $86 From $81

Viking Holdings (VIK) has an average rating of overweight and mean price target of $92, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$VIK
Research

TD Cowen Upgrades FirstEnergy to Buy From Hold, Adjusts Price Target to $53 From $56

FirstEnergy (FE) has an average rating of overweight and mean price target of $52.83, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$FE
Research

Evercore ISI Initiates J.M. Smucker at Outperform With $117 Price Target

J.M. Smucker (SJM) has an average rating of overweight and mean price target of $117.87, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$SJM